The Geneva-based clinical laboratory testing group, Unilabs, says interim net profit was 16 per cent higher at SFr6.5 million ($4 million) over the six months to November last year.
The group says the acceleration of growth in the second half of its financial year is down to strong internal expansion and the start of new hospital laboratory contracts.
It expects full year revenue to rise by 15 to 20 per cent to between SFr190 and SFr200 million.
However, shares in the group have come under pressure on the Swiss bourse because the forecast profit is slightly lower than expected.
The company put this down to the delayed start of Spanish hospital contracts.
swissinfo with agencies